0R15 8520.0 0.0% 0R1E 8203.0 0.0% 0M69 21090.0 67.5139% 0R2V 226.02 9878.8079% 0QYR None None% 0QYP 412.97 -2.8306% 0RUK 2652.0 -9.2402% 0RYA 1554.0 -0.7029% 0RIH 174.55 -1.3563% 0RIH 165.15 -5.3853% 0R1O 198.5 9800.2494% 0R1O None None% 0QFP None None% 0M2Z 267.777 -0.1763% 0VSO 32.05 -9.9846% 0R1I None None% 0QZI 559.0 0.7207% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 165.7358 2.7149%
The Offer
Company Overview
SKWD is a developing specialty insurance provider that offers non-admitted and admitted business P&C products and solutions, mostly in the United States. Areas that are underserved, disconnected, or for which typical insurance coverages are insufficient or inadequate to fulfill the demands of enterprises, including the clients and potential clients operating in these markets, are where SKWD concentrates its activity. Customers of SKWD often need underwriting solutions and claims capabilities that are highly specialized and specifically tailored. To cater to each of the specialty markets it serves, SKWD creates and provides customized insurance products and services.
Key Highlights
Primary Offering: Based on an offering price of USD 16.00, the total gross proceeds to the business, before underwriting discounts and expenses, will be USD 156,400,000. The company intends to issue 8,500,000 shares with 4,750,000 shares by SKWD and 3,750,000 shares by stockholders. Additionally, with an option for the underwriters to acquire up to an additional 1,275,000 shares from the selling shareholders, exercisable for 30 days from the date of this prospectus. Based on the projected initial public offering price of USD 15.00 per share, the company anticipates that the net proceeds to the business from the sale of shares of its common stock in this offering would be close to USD 61.8 million.
Use of proceeds:
Based on the projected initial public offering price of USD 15.00 per share, the company anticipates that the net proceeds to the business from the sale of shares of its common stock in this offering would be close to USD 61.8 million. The main goals of this offering are to expand capitalization and financial flexibility, establish a public market for SKWD common stock, and give the firm and its investors access to the public equity markets. To expand its insurance company subsidiaries' businesses, SKWD plans to spend at least USD 45 million of the net proceeds from this offering as capital contributions, with the remaining funds going toward general corporate objectives. SKWD plans to invest the net proceeds from the offering in line with the investment strategy chosen by the Investment Committee, pending the utilization of the funds as stated above.
Dividend policy: Although SKWD has paid dividends in the past, it now intends to save any further revenues for use in running the company and has no immediate plans to declare or pay any cash dividends. The board of directors will decide whether to pay dividends on the capital stock in the future at their discretion, subject to any applicable laws, and considering the company's financial situation, operational performance, capital needs, general business environment, and other relevant considerations. The conditions of any future debt securities, preferred stock, or credit facility may potentially place restrictions on SKWD's capacity to pay cash dividends on the common stock in the future.
Industry and competitive analysis
Financial Highlights (Expressed in USD):
Investment Portfolio
The portfolio for cash and short-term investments is made up of cash, cash equivalents, money market funds, and other short-term assets with a short duration (less than a year). Investment grade fixed income instruments, typically highly rated and liquid bonds, make up most of the Core Fixed Income portfolio. The Core Fixed Income portfolio's goal for SKWD is to generate appealing risk-adjusted returns with little chance of principal loss. Third-party managers oversee the Core Fixed Income portfolio.
Promissory notes, limited partnerships, equity holdings, and separately managed accounts make up the Opportunistic Fixed Income portfolio. The underlying assets are mostly floating-rate senior secured loans, which are asset-oriented, short-term, collateralized credit investments with good risk-adjusted returns. Strong covenants and a considerable quantity of collateral are used to underpin investments, which often have a loan-to-value ratio of 60% or more.
Publicly traded domestic preferred stocks, ordinary stocks, exchange-traded funds, limited partnerships, limited liability corporations, and other equity assets make up the bulk (74.1%) of the components of the equity portfolio. With the intention of safeguarding the stock portfolio from a significant decrease in the S&P 500 within a 30-day window, SKWD began a tail-risk management strategy in 2021. SKWD maintained this policy for the fiscal year that ended on September 30, 2022.
Key Management Highlights
Risk Associated (High)
Investment in the IPO of “SKWD” is exposed to a variety of risks such as:
Conclusion
In comparison to the nine months ending September 30, 2021, net written premiums increased by USD 107.4 million, or 27.7%, to USD 495.6 million for the nine months ending September 30, 2022. The rise in gross written premiums was the primary factor in the expansion of net written premiums. Additionally, the income was decreased because of rising losses and LAEs in addition to rising costs for underwriting, insurance, and acquisitions. Additionally, for the nine months ending September 30, 2022, SKWD earned annualized adjusted ROE and annualized adjusted return on tangible equity of 15.2% and 19.4%, respectively. SKWD has a well-diversified portfolio divided among different asset classes, but still, the company is prone to the risk highlighted in the risk section.
Hence, given the financial performance of the company for the nine months ending September 30, 2022, increased revenue, industry analysis, use of proceeds, and associated risks “Skyward Specialty Insurance Group, Inc. (SKWD)” IPO seems “Attractive" at the IPO price.
Disclaimer
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.
Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.
Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.